Vascular endothelial growth factor (VEGF) is the most relevant mediator of tumor-associated angiogenesis, and its evaluation at both mRNA and protein levels has confirmed its correlation with disease progression and poor clinical outcome [7–9]. This evidence concerns the gene VEGFA and neoplasm.